Clarivate Plc (NYSE:CLVT – Get Free Report) was the recipient of a large decline in short interest in June. As of June 15th, there was short interest totalling 32,190,000 shares, a decline of 35.5% from the May 31st total of 49,910,000 shares. Currently, 8.0% of the shares of the stock are short sold. Based on an average daily volume of 4,590,000 shares, the short-interest ratio is currently 7.0 days.
Institutional Trading of Clarivate
Hedge funds have recently added to or reduced their stakes in the business. Edmond DE Rothschild Holding S.A. bought a new stake in Clarivate in the fourth quarter worth $25,576,000. Glenview Capital Management LLC raised its stake in shares of Clarivate by 22.2% during the fourth quarter. Glenview Capital Management LLC now owns 24,651,047 shares of the company’s stock valued at $228,269,000 after acquiring an additional 4,472,302 shares during the last quarter. Confluence Investment Management LLC bought a new position in shares of Clarivate during the first quarter valued at about $18,389,000. Baupost Group LLC MA raised its stake in shares of Clarivate by 13.3% during the fourth quarter. Baupost Group LLC MA now owns 25,500,000 shares of the company’s stock valued at $236,130,000 after acquiring an additional 3,000,000 shares during the last quarter. Finally, Norges Bank bought a new position in shares of Clarivate during the fourth quarter valued at about $54,457,000. 85.72% of the stock is owned by institutional investors.
Clarivate Stock Down 0.2 %
Shares of NYSE:CLVT opened at $5.69 on Friday. Clarivate has a 52-week low of $5.19 and a 52-week high of $10.03. The firm has a fifty day moving average of $6.08 and a 200 day moving average of $7.52. The firm has a market capitalization of $3.80 billion, a PE ratio of -3.43, a price-to-earnings-growth ratio of 3.85 and a beta of 1.20. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.86 and a current ratio of 0.86.
Analyst Ratings Changes
Separately, The Goldman Sachs Group reduced their price target on shares of Clarivate from $8.50 to $7.50 and set a “buy” rating for the company in a research report on Thursday, May 9th. Three analysts have rated the stock with a sell rating, three have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $7.78.
Get Our Latest Research Report on Clarivate
Clarivate Company Profile
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Recommended Stories
- Five stocks we like better than Clarivate
- Stock Average Calculator
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- What is the Euro STOXX 50 Index?
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.